Literature DB >> 29530425

Medical treatment of endometriosis-related pain.

Paolo Vercellini1, Laura Buggio2, Maria Pina Frattaruolo3, Alessandra Borghi4, Dhouha Dridi5, Edgardo Somigliana6.   

Abstract

Available medical treatments for symptomatic endometriosis act by inhibiting ovulation, reducing serum oestradiol levels, and suppressing uterine blood flows. For this, several drugs can be used with a similar magnitude of effect, in terms of pain relief, independently of the mechanism of action. Conversely, safety, tolerability, and cost differ. Medications for endometriosis can be categorized into low-cost drugs including oral contraceptives (OCs) and most progestogens, and high-cost drugs including dienogest and GnRH agonists. As the individual response to different drugs is variable, a stepwise approach is suggested, starting with OCs or low-cost progestogens, and stepping up to high-cost drugs only in case of inefficacy or intolerance. OCs may be used in women with dysmenorrhea as their main complaint, and when only superficial peritoneal implants or ovarian endometriomas <5 cm are present, while progestogens should be preferred in women with severe deep dyspareunia and when infiltrating lesions are identified.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Endometriosis; GnRH agonists; GnRH antagonists; Oral contraceptives; Pelvic pain; Progestogens

Mesh:

Substances:

Year:  2018        PMID: 29530425     DOI: 10.1016/j.bpobgyn.2018.01.015

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  22 in total

1.  Endometriosis and Cannabis Consumption During the COVID-19 Pandemic: An International Cross-Sectional Survey.

Authors:  Mike Armour; Justin Sinclair; Junipearl Cheng; Preston Davis; Aaish Hameed; Harini Meegahapola; Krithika Rajashekar; Sunethra Suresh; Andrew Proudfoot; Mathew Leonardi
Journal:  Cannabis Cannabinoid Res       Date:  2022-01-28

2.  Comorbidities and Quality of Life in Women Undergoing First Surgery for Endometriosis: Differences Between Chinese and Italian Population.

Authors:  Huixi Chen; Silvia Vannuccini; Tommaso Capezzuoli; Marcello Ceccaroni; Liu Mubiao; Huang Shuting; Yanting Wu; Hefeng Huang; Felice Petraglia
Journal:  Reprod Sci       Date:  2021-03-09       Impact factor: 3.060

Review 3.  Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment.

Authors:  Edgardo Rolla
Journal:  F1000Res       Date:  2019-04-23

4.  Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg -levonorgestrel 0.09 mg for dysmenorrhea: A placebo-controlled, double-blind, randomized trial.

Authors:  Tasuku Harada; Mikio Momoeda
Journal:  Reprod Med Biol       Date:  2021-02-27

5.  Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial.

Authors:  Eissa Khalifa; Hashem Mohammad; Ameer Abdullah; Mazen Abdel-Rasheed; Mohammed Khairy; Mahmoud Hosni
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-30       Impact factor: 3.007

Review 6.  Endometriosis and pain in the adolescent- striking early to limit suffering: A narrative review.

Authors:  Christine B Sieberg; Claire E Lunde; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2019-12-17       Impact factor: 8.989

7.  Towards a more biologically informative system of endometriosis classification.

Authors:  Velja Mijatovic
Journal:  Hum Reprod       Date:  2020-12-01       Impact factor: 6.353

8.  Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.

Authors:  Fernando M Reis; Larissa M Coutinho; Silvia Vannuccini; Frédéric Batteux; Charles Chapron; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

Review 9.  Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?

Authors:  Ryan M Marquardt; Tae Hoon Kim; Jung-Ho Shin; Jae-Wook Jeong
Journal:  Int J Mol Sci       Date:  2019-08-05       Impact factor: 5.923

Review 10.  Purinergic Signaling in Endometriosis-Associated Pain.

Authors:  Carla Trapero; Mireia Martín-Satué
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.